Analysis of nicked DNA by matched ion polynucleotide chromatography

• US 6,187,539 B1
• Filed: 10/14/1998
• Issued: 02/13/2001
• Est. Priority Date: 10/14/1997
• Status: Expired due to Fees

• Current Assignee: Transgenomic, Inc. (Precipio, Inc.)
• Original Assignee: Transgenomic, Inc. (Precipio, Inc.)
• Inventors: Gjerde, Douglas T., Taylor, Paul D.
• Primary Examiner(s): Marschel, Ardin H.
• Application Number:
  US09/172,920
• Time in Patent Office: 853 Days
• Field of Search: 435/6, 536/25.3, 536/25.4
• US Class Current: 435/6.12
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 2565/131 Single/double strand conformational analysis, i.e. SSCP/DSCP
• CPC Class Codes: C12Q 2565/137 Chromatographic separation

Abstract

The present invention provides a method for calibrating a MIPC column wherein the calibration relates to the determination of the organic solvent component in the mobile phase required to elute dsDNA fragments of different base pair lengths at specific retention times. Since a MIPC column affords highly reproducible separations, once calibrated, the base pair length of unknown dsDNA fragments can be determined by comparing their retention times to those obtained on a standard calibration chromatogram. The standard calibration chromatogram is obtained by chromatographing a standard dsDNA ladder containing fragments of known base pair length. In addition, a method is provided to determine the presence of nicks in dsDNA using MIPC under fully denaturing conditions, e.g., 80° C. In one embodiment, this method is applied to the detection of mutations in dsDNA.

Claims

1. A method for separating a nicked fragment of double stranded DNA from an un-nicked fragment of double stranded DNA having the same base pair length as the nicked fragment, the method comprising:

a) applying said fragments to a Matched Ion Polynucleotide Chromatography column, and

b) eluting said fragments under non-denaturing conditions.

2. A method of claim 1 including the additional step of

c) detecting the eluted fragments.

3. A chromatographic method for analyzing a sample of double stranded DNA to determine the presence of a mutation in said sample, the method comprising:

a) separating a first aliquot of said sample using Matched Ion Polynucleotide Chromatography under non-denaturing conditions to produce a first chromatogram comprising peaks or other shapes which represent separated components of the sample;

b) contacting another aliquot of said sample with a mutation site binding reagent under conditions which allow said reagent to nick a strand of DNA at or near the site of a base pair mismatch;

c) separating the product of step (b) by repeating the chromatographic method of step (a) to produce a second chromatogram; and

d) comparing the first and second chromatograms to determine the presence or absence of a change in the retention time of one of the peaks, wherein a variance in the retention times of one of the fractions indicates the presence of a mutation in said sample.

4. A method of claim 3, wherein said sample of double stranded DNA is the product of a hybridization of a DNA sample suspected of containing a mutation with corresponding wild type DNA.

5. A method of claim 3, wherein said mutation binding reagent is an enzyme.

6. A method of claim 5, wherein said enzyme is selected from the group consisting of mismatch repair enzymes, S1 nuclease, mung bean endonuclease, CEL 1, MutY protein, MutS protein, MutH protein, MutL protein, cleavase, exonuclease III, and HINF1.

7. A method of claim 3 wherein said mutation site binding reagent is a non-proteinaceous chemical reagent.

8. A method of claim 7 wherein said chemical reagent is an organometallic DNA intercalator.

9. A method of claim 8 wherein said intercalator contains rhodium or ruthenium.

10. A method of claim 8 wherein said intercalator is selected from the group consisting of bis(2,2′

-bipyridyl)chrysenequinone diimine rhodium(III), bis(2,2′

-bipyridyl)chrysenequinone diimine rhodium(III), (2,2′

-bipyridyl)-bis(phenanthrenequinone) diimine rhodium(III), (bis(phenanthroline)dipyridophenazine ruthenium(II), and bis(phenanthroline)dipyridophenazine ruthenium(III).